Caredx Lab Solutions Inc.

West Chester, PA Caredx Lab Solutions Inc. Part of Caredx, Inc.

UEI
KHHBJ9FJR225
CAGE
6E5A4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
  • Caredx, Inc. Parent Y371A27ZEUM4
    • Caredx Lab Solutions Inc. KHHBJ9FJR225
SAM.gov registration date
Physical address
901 S Bolmar St r, West Chester, PA 19382, USA
Website
caredx.com
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Caredx Lab Solutions Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Caredx allomap Contract · 36C25726N0188 Veterans Integrated Service Network 17 $59,932
26-000014 caredx lab solutions INC. Allo SEQ TX17 next generation sequencing (NGS) reagent kits Contract · 75N90026P00061 NIH Clinical Center $292,973
Caredx lab solutions, INC. Contract · N3239825P0044 Bureau of Medicine and Surgery $200,000
Caredx allomap Contract · 36C25725N0202 Veterans Integrated Service Network 17 $29,966
25-000009 caredx lab solutions INC allo SEQ TX 17 next generation sequencing (NGS) reagent kits Contract · 75N90025P00083 NIH Clinical Center $279,096

About Caredx Lab Solutions Inc.

Caredx Lab Solutions Inc., a West Chester, Pennsylvania-based subsidiary of Caredx, Inc., manufactures FDA-approved genomics-based diagnostic tests and next-generation sequencing reagent kits for federal healthcare and research agencies as a prime contractor, competing on technical capability without set-aside designations across 34 recent awards valued at $8.8 million combined potential.

The company specializes in transplant diagnostics, particularly the proprietary AlloMap molecular test for post-transplant heart recipients and AlloSeq TX17 next-generation sequencing reagent kits for HLA typing and immunosuppression assessment. Caredx Lab Solutions operates as a manufacturer and diagnostic service provider, with performance split between its West Chester headquarters and a Rockville, Maryland facility. The company has competed exclusively as a full-and-open prime contractor on individual purchase orders and delivery orders; no subcontract work or set-aside activity appears in the source.

Customer concentration skews toward NIH Clinical Center and the Department of Veterans Affairs, but with notable value concentration at the Army Medical Command. The NIH Clinical Center accounts for 14 awards (41% of total awards) with $1.2 million combined potential value, including purchase orders for AlloSeq TX17 NGS reagent kits valued at $243 thousand, $279 thousand, and $292 thousand awarded in 2023–2026. Veterans Integrated Service Network 17 holds six awards with $956 thousand combined potential value, anchored by a $787,000 single-award indefinite delivery contract (awarded June 3, 2022, running through June 2027) for AlloMap molecular testing services; five delivery orders issued under this IDC between June 2022 and June 2026 ranged from $6,480 to $59,932 per order. The Department of the Navy Bureau of Medicine and Surgery placed four awards totaling $689 thousand, including a $200,000 purchase order with the Naval Medical Research Command's Bone Marrow Program (July 2025–July 2026) and a $250,000 sole-source purchase order for Stage 1 optimization reagents supporting NGS assay development for hematopoietic stem cell transplant protocols (June 2024). The Department of Health and Human Services Centers for Disease Control and Prevention awarded two orders for ASTX17.1 testing kits totaling $260 thousand. Two Army Medical Command awards carry $5.5 million combined potential value, significantly outweighing other customer relationships by dollar magnitude, though their scope and contract type are not detailed in the source.

Award activity has declined year over year — five awards in 2022 declining to two in 2026 — and three awards with combined potential value of $553 thousand face ultimate completion within the next twenty-four months, triggering recompete exposure on the VA VISN 17 IDC and related purchase orders. The company holds positions on an indefinite delivery contract (36C25722D0051) with five task orders totaling $169 thousand and a blanket purchase agreement (W91YTZ11A0042) with one $27,000 task order. No parent vehicles such as GWACs or agency-wide IDIQs are listed; work flows through agency-specific contracts and IDCs. Performance categories reflect the company's manufacturing footprint: Research and Development in Biotechnology (8 awards), Medical Laboratories (6 awards), Analytical Laboratory Instrument Manufacturing (5 awards), and In-Vitro Diagnostic Substance Manufacturing (3 awards). The company's federal business is narrowly focused on transplant diagnostics, reagent supply, and specialized molecular testing services to support organ transplant care across the VA, NIH Clinical Center, DoD medical facilities, and CDC.

Quick answers

What is Caredx Lab Solutions Inc.'s UEI?

Caredx Lab Solutions Inc.'s Unique Entity ID (UEI) in SAM.gov is KHHBJ9FJR225.

What is Caredx Lab Solutions Inc.'s CAGE code?

Caredx Lab Solutions Inc.'s CAGE code is 6E5A4.

What is Caredx Lab Solutions Inc.'s primary NAICS code?

Caredx Lab Solutions Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Caredx Lab Solutions Inc. located?

Caredx Lab Solutions Inc.'s physical address in SAM.gov is 901 S Bolmar St r, West Chester, PA 19382, USA.

Is Caredx Lab Solutions Inc. registered in SAM.gov?

Yes. Caredx Lab Solutions Inc.'s SAM.gov registration is active through May 18, 2027.

Who is Caredx Lab Solutions Inc.'s parent company?

Caredx Lab Solutions Inc. is part of Caredx, Inc.

What is Caredx Lab Solutions Inc.'s most recent federal award?

Caredx Lab Solutions Inc.'s most recent federal contract award is Caredx allomap (36C25726N0188), from Veterans Integrated Service Network 17, on June 3, 2026.

On GovTribe

See Caredx Lab Solutions Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors